Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice
Open Access
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 18 (8) , 1158-1161
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Results of three analytical approaches on long-term efficacy of etanercept for psoriasis in daily practiceJournal of the American Academy of Dermatology, 2013
- Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trialsBritish Journal of Dermatology, 2011
- Long-term efficacy of etanercept for psoriasis in daily practiceBritish Journal of Dermatology, 2011
- Etanercept: effectiveness and safety data of a retrospective studyJournal of the European Academy of Dermatology and Venereology, 2011
- Etanercept: Efficacy and safetyJournal of the European Academy of Dermatology and Venereology, 2009
- Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centreBritish Journal of Dermatology, 2008
- Two years of experience with etanercept in recalcitrant psoriasisBritish Journal of Dermatology, 2007
- A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reductionBritish Journal of Dermatology, 2005
- A Randomized Trial of Etanercept as Monotherapy for PsoriasisArchives of Dermatology, 2003
- Etanercept as Monotherapy in Patients with PsoriasisNew England Journal of Medicine, 2003